Photodynamic therapy for prostate cancer--a review of current status and future promise.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyVascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insightPermanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with TookadFocal therapy in prostate cancer: the current situationHeme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation targetIn vivo visualization of prostate brachytherapy seeds with photoacoustic imaging.Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedureImidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers.A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation.The positive influence of fullerene derivatives bonded to manganese(III) porphyrins on water proton relaxation.Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapyFluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model.Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.[Focal prostate cancer therapy: capabilities, limitations and prospects].Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy.Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer.Novel ZnO:Ag nanocomposites induce significant oxidative stress in human fibroblast malignant melanoma (Ht144) cellsHighly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumourFocal therapy for prostate cancer - where are we in 2011?Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption.A heterogeneous algorithm for PDT dose optimization for prostateNano-enabled SERS reporting photosensitizers.A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDTEnhanced photodynamic efficacy and efficient delivery of Rose Bengal using nanostructured poly(amidoamine) dendrimers: potential application in photodynamic therapy of cancerTOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer.Focal therapy in the management of prostate cancer: an emerging approach for localized prostate cancer.Cell death signaling and anticancer therapyDual-Modality Positron Emission Tomography/Optical Image-Guided Photodynamic Cancer Therapy with Chlorin e6-Containing NanomicellesEvaluation of Hydrogel Suppositories for Delivery of 5-Aminolevulinic Acid and Hematoporphyrin Monomethyl Ether to Rectal Tumors.Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicleAdvances and future directions in management of prostate cancer.Biomodulatory approaches to photodynamic therapy for solid tumorsPolymer-drug conjugates for intracellar molecule-targeted photoinduced inactivation of protein and growth inhibition of cancer cellsVascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning.Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer.Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery.Mitochondria-targeted Triphenylamine Derivatives Activatable by Two-Photon Excitation for Triggering and Imaging Cell ApoptosisPhotodynamic therapy for gynecological diseases and breast cancerOut-of-Plane Coordinated Porphyrin Nanotubes with Enhanced Singlet Oxygen Generation Efficiency
P2860
Q26745710-0CC9B6D1-CAE5-42A8-8BCE-D3441B84FB44Q26750559-77F920AA-AF74-4BC0-8A87-DEC8C8099569Q27330438-D4E1CA1D-B369-4B76-99A6-F9B407A96F7CQ28242346-BB376AC4-F069-4DA1-82FA-F41DDC3AC8A3Q28471656-DA49F237-E66C-4E59-957A-C14FC5FF32D6Q30395537-1ED1A137-6A3C-43B3-A556-0CABF7F00663Q30408124-D9E34033-4B38-4CEA-B33D-604734A33483Q30514153-85A28B51-E975-423C-B3B4-1092949E447DQ30586290-C191FEB1-87BD-40E5-A7F2-4A07D291DDDCQ30938206-428018CA-336B-4424-968E-CD6F1DB381C5Q33955386-1932A5D1-07BC-4DB4-AF4C-D98F9F31E234Q33962146-CA26FCE3-666A-4F56-AB27-CB57CF1CDBAAQ34105908-30B24501-8114-4F42-A87E-1EC75CCE1BDEQ34448994-78AC95C8-446D-4A32-B8E1-7317C83A0C61Q34768606-61143AAB-B180-47E1-A212-C5AF31400E9EQ34780593-CC0D5D1D-E052-4688-937E-25744C1C24ADQ34944351-39AC83AE-675A-481D-A1F6-1E70C2A5F941Q35183270-48E9100B-6835-4878-B02C-CBB63BAAC059Q35196929-5E67E451-7C7D-48B8-8D90-99299CBBF4A1Q35220196-8E63F795-1C7A-44ED-8EDA-1A238B61B624Q35446818-FF3CCEBD-B625-43C1-8ECB-5A6C72FA49A3Q35531748-5A88A7A7-796C-4B12-A29D-69C3FCAA7843Q35576471-AF6ABF50-AC92-4534-A796-B18D9FF2490AQ35619285-AADFC583-832F-4613-A2B5-04A7AD894546Q35672624-F3695DD4-2775-436D-BFD0-1C9838C8138EQ35780014-584C1884-501B-4F63-B80D-E971A0A2956AQ35944856-2E3FB098-D173-421B-B40C-2466B79B9EB5Q35972102-507A11E3-11D9-4509-ABD6-ED269882FC06Q36085944-33300E37-CD40-490D-947F-A019A8226EF3Q36165888-E3E79A50-6B62-4FAA-B123-4AF6E36830F6Q36223305-334F9272-48A1-4D8E-8C88-ABAD556A44F9Q36262329-1A591D35-07E5-4A8B-A578-050DB8C98986Q36283013-B6EFA73B-04AC-44BF-87CA-BF6C244AEC42Q36342403-A1130BD5-A8BF-4F70-9A14-6310A1BB5601Q36388895-075701C5-DDDC-4465-94DB-C62A98BE4C05Q36412424-C5E2CD76-DD0C-444E-9EDF-3C0A38CB11FDQ36458544-3A5C4EF6-0187-499E-9C1C-58C6150AE42CQ36657146-5DAA2DA4-6256-49BF-9FF7-339791A008EAQ36814295-3086E076-D9DE-4576-AE9A-6A097861C7CEQ37177020-696D3771-A174-423A-B63B-8121A708520D
P2860
Photodynamic therapy for prostate cancer--a review of current status and future promise.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Photodynamic therapy for prostate cancer--a review of current status and future promise.
@ast
Photodynamic therapy for prostate cancer--a review of current status and future promise.
@en
type
label
Photodynamic therapy for prostate cancer--a review of current status and future promise.
@ast
Photodynamic therapy for prostate cancer--a review of current status and future promise.
@en
prefLabel
Photodynamic therapy for prostate cancer--a review of current status and future promise.
@ast
Photodynamic therapy for prostate cancer--a review of current status and future promise.
@en
P356
P1476
Photodynamic therapy for prostate cancer--a review of current status and future promise.
@en
P2093
Caroline M Moore
Doug Pendse
P2888
P356
10.1038/NCPURO1274
P407
P577
2009-01-01T00:00:00Z
P6179
1020857869